Agreement with Karolinska Institutet
Glucox Biotech has signed an agreement with Prof. Anders Arner of Karolinska Institutet for further...
X. Wu and coworkers show importance of NOX4 in insulin resistance
Wu and coworkers undertook characterization of pathway-selective insulin resistance and responsivenes...
New publication from Glucox Biotech and academic partners
The mission of Glucox Botech is to identify compounds that improve glucose homeostasis. Together with...
Agreement with Redoxis AB
Glucox Biotech announceed today the signing of a contract with Redoxis AB for further studie on Glucox...
Change of CEO and Chair
Erik Walum, former Chair of the Board of Directors was today appointed new CEO of Glucox Biotech...
Approval of patent in Europe
Glucox Biotech has been approved its third patent application in Europe in April 2010. The examining...
Initiation of aminal studie case for novel compounds
Glucox Biotech has initiated a comprehensive animal study to confirm a proof-of-concept with the...